Alexis D. Leal

^Non-V600<i>BRAF</i> Mutations Define a Clinically Distinct Molecular Subtype of Metastatic Colorectal Cancer

Jeremy Jones, Lindsay A. Renfro, Humaid O. Al‐Shamsi et al. · Journal of Clinical Oncology · 2017 · 352 citations · Full text

Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trial

Shubham Pant, Zev A. Wainberg, Colin D. Weekes et al. · Nature Medicine · 2024 · 190 citations · Full text

North Central Cancer Treatment Group/Alliance trial N08CA—the use of glutathione for prevention of paclitaxel/carboplatin‐induced peripheral neuropathy: A phase 3 randomized, double‐blind, placebo‐controlled study

Alexis D. Leal, Rui Qin, Pamela J. Atherton et al. · Cancer · 2014 · 84 citations · Full text

Fosaprepitant-induced phlebitis: a focus on patients receiving doxorubicin/cyclophosphamide therapy

Alexis D. Leal, Kunal C. Kadakia, Sherry Looker et al. · Supportive Care in Cancer · 2014 · 49 citations · Full text

Fosaprepitant-induced Phlebitis, Medicine, Clinical Pharmacology +4

Anthropometric, medical history and lifestyle risk factors for myeloproliferative neoplasms in The Iowa Women's Health Study cohort

Alexis D. Leal, Carrie A. Thompson, Alice H. Wang et al. · International Journal of Cancer · 2013 · 48 citations · Full text